Healthco Healthcare And Stock Revenue
| HCW Stock | 1.04 0.01 0.95% |
Healthco Healthcare and fundamentals help investors to digest information that contributes to Healthco Healthcare's financial success or failures. It also enables traders to predict the movement of Healthco Stock. The fundamental analysis module provides a way to measure Healthco Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthco Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 73.8 M | 50.8 M |
Healthco |
Healthco Healthcare and Company Revenue Analysis
Healthco Healthcare's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Healthco Healthcare Revenue | 73.8 M |
Most of Healthco Healthcare's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthco Healthcare and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Healthco
Projected quarterly revenue analysis of Healthco Healthcare and provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Healthco Healthcare match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Healthco Healthcare's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Healthco Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Healthco Healthcare and reported 73.8 M of revenue. This is 95.13% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The revenue for all Australia stocks is 99.22% higher than that of the company.
Healthco Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthco Healthcare's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthco Healthcare could also be used in its relative valuation, which is a method of valuing Healthco Healthcare by comparing valuation metrics of similar companies.Healthco Healthcare is currently under evaluation in revenue category among its peers.
Healthco Fundamentals
| Return On Equity | 0.0078 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.71 % | ||||
| Current Valuation | 1.05 B | ||||
| Shares Outstanding | 561 M | ||||
| Shares Owned By Insiders | 24.40 % | ||||
| Shares Owned By Institutions | 20.11 % | ||||
| Price To Book | 0.64 X | ||||
| Price To Sales | 8.22 X | ||||
| Revenue | 73.8 M | ||||
| Gross Profit | 21.44 M | ||||
| EBITDA | 34.7 M | ||||
| Net Income | 6.9 M | ||||
| Total Debt | 481.1 M | ||||
| Book Value Per Share | 1.62 X | ||||
| Cash Flow From Operations | 6.4 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Target Price | 1.39 | ||||
| Beta | 0.79 | ||||
| Market Capitalization | 591.88 M | ||||
| Total Asset | 1.44 B | ||||
| Retained Earnings | (27 M) | ||||
| Working Capital | 12.1 M | ||||
| Annual Yield | 0.08 % | ||||
| Net Asset | 1.44 B | ||||
| Last Dividend Paid | 0.08 |
About Healthco Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healthco Healthcare and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthco Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthco Healthcare and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Healthco Stock Analysis
When running Healthco Healthcare's price analysis, check to measure Healthco Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthco Healthcare is operating at the current time. Most of Healthco Healthcare's value examination focuses on studying past and present price action to predict the probability of Healthco Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthco Healthcare's price. Additionally, you may evaluate how the addition of Healthco Healthcare to your portfolios can decrease your overall portfolio volatility.